Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price objective lifted by analysts at Evercore ISI from $1,275.00 to $1,400.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an "outperform" rating on the medical instruments supplier's stock. Evercore ISI's price objective would suggest a potential upside of 6.00% from the stock's previous close.
Other analysts have also recently issued reports about the company. Barclays increased their price objective on Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an "overweight" rating in a research note on Thursday, October 2nd. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Weiss Ratings reissued a "hold (c)" rating on shares of Mettler-Toledo International in a report on Saturday, September 27th. Citigroup increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Finally, Bank of America raised their price objective on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a "neutral" rating in a report on Monday, September 22nd. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of "Hold" and a consensus price target of $1,342.22.
Read Our Latest Research Report on Mettler-Toledo International
Mettler-Toledo International Price Performance
NYSE MTD traded down $24.47 during trading hours on Tuesday, reaching $1,320.81. The company's stock had a trading volume of 84,900 shares, compared to its average volume of 167,393. The firm has a market capitalization of $27.21 billion, a price-to-earnings ratio of 33.51, a P/E/G ratio of 3.94 and a beta of 1.37. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,486.76. The company's 50-day moving average is $1,273.95 and its two-hundred day moving average is $1,187.04.
Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. During the same period in the prior year, the business earned $9.65 earnings per share. The business's revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer owned 5,095 shares in the company, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gerry Keller sold 165 shares of the business's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at $123,012.16. This represents a 63.71% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 1,827 shares of company stock valued at $2,371,208. Company insiders own 0.77% of the company's stock.
Institutional Investors Weigh In On Mettler-Toledo International
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Merit Financial Group LLC acquired a new stake in shares of Mettler-Toledo International in the 1st quarter worth approximately $511,000. UMB Bank n.a. lifted its stake in shares of Mettler-Toledo International by 13.4% in the 1st quarter. UMB Bank n.a. now owns 144 shares of the medical instruments supplier's stock worth $170,000 after acquiring an additional 17 shares during the period. Park Avenue Securities LLC lifted its stake in shares of Mettler-Toledo International by 7.2% in the 1st quarter. Park Avenue Securities LLC now owns 297 shares of the medical instruments supplier's stock worth $351,000 after acquiring an additional 20 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after acquiring an additional 25 shares during the period. Finally, GAMMA Investing LLC lifted its stake in shares of Mettler-Toledo International by 11.2% in the 1st quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier's stock worth $386,000 after acquiring an additional 33 shares during the period. Institutional investors own 95.07% of the company's stock.
About Mettler-Toledo International
(
Get Free Report)
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.